期刊文献+

诱骗受体3γ-干扰素和抗环瓜氨酸肽抗体在风湿性关节炎患者血清中的表达 被引量:1

Expression of Decoy Receptor 3γ-Interferon and Anti-Cyclic Citrullinated Peptide Antibody in Serum of Patients with Rheumatoid Arthritis
下载PDF
导出
摘要 目的分析在风湿性关节炎患者中抗环瓜氨酸肽抗体、血清诱骗受体3γ-干扰素检验有效性。方法选择2018年1月~12月我院收治的风湿性关节炎患者50例作为观察组,另选同期体检健康人群40例作为对照组,检测并比较两组血清抗环瓜氨酸肽抗体、血清诱骗受体3γ-干扰素水平。结果观察组抗环瓜氨酸肽抗体、风湿因子检测结果高于对照组,差异有统计学意义(P<0.05);观察组单一抗环瓜氨酸肽抗体检测阳性率、单一风湿因子检测阳性率均高于对照组,观察组抗环瓜氨酸肽抗体联合风湿因子检测阳性率高于对照组,差异均有统计学意义(P<0.05);观察组抗环瓜氨酸肽抗体、血清诱骗受体3γ-干扰素含量比对照组高,差异有统计学意义(P<0.05)。结论在风湿性关节炎患者中抗环瓜氨酸肽抗体、血清诱骗受体3γ-干扰素检验,能够明确患者临床指标情况,对于临床治疗有参考价值,值得应用。 Objective To analyze the effectiveness of anti-cyclic citrullinated peptide antibody and serum decoy receptor 3γ-interferon in patients with rheumatoid arthritis.Methods 50 patients with rheumatoid arthritis admitted to our hospital from January to December 2018 were selected as observation group,and 40 healthy subjects in the same period were selected as the control group.The serum anti-cyclic citrullinated peptide antibodies were detected and compared.Serum decoy receptor 3γ-interferon levels.Results The anti-cyclic citrullinated peptide antibody and rheumatoid factor in the observation group were higher than the control group,the difference was statistically significant(P<0.05).The positive rate of single anti-cyclic citrullinated peptide antibody and the positive rate of single rheumatoid factor in the observation group.The positive rate of anti-cyclic citrullinated peptide antibody combined with rheumatoid factor was higher in the observation group than in the control group,the difference was statistically significant(P<0.05);the anti-cyclic citrullinated peptide antibody and serum decoy in the observation group The content of receptor 3γ-interferon was higher than that of the control group,the difference was statistically significant(P<0.05).Conclusion In the patients with rheumatoid arthritis,anti-cyclic citrullinated peptide antibody and serum decoy receptor 3γ-interferon test can confirm the clinical indicators of patients,which has reference value for clinical treatment and is worthy of application.
作者 郑伟 ZHENG Wei(Department of Clinical Laboratory,Mongolian Medical Hospital of Mongolian Autonomous County,Fuxin 123100,Liaoning,China)
出处 《医学信息》 2019年第19期97-98,101,共3页 Journal of Medical Information
关键词 血清诱骗受体3γ-干扰素 抗环瓜氨酸肽抗体 风湿性关节炎 Serum decoy receptor 3γ-interferon Anti-cyclic citrullinated peptide antibody Rheumatoid arthritis
  • 相关文献

二级参考文献50

  • 1王利军,杨林花,李小峰.细胞因子在类风湿关节炎血小板升高机制中的作用及研究进展[J].中华风湿病学杂志,2005,9(1):53-55. 被引量:12
  • 2钱捷,沈南,郭桂梅,万年红,林燕,黄新芳,吴慧,陈顺乐.系统性红斑狼疮患者干扰素调节因子IRF1 IRF4 IRF8基因表达的研究[J].中华风湿病学杂志,2006,10(9):513-516. 被引量:6
  • 3李玉珍.抗β_2-糖蛋白Ⅰ抗体在RSA患者血清中的表达及意义[J].山东医药,2007,47(20):69-69. 被引量:2
  • 4Nutt SL, Tarlinton DM. Germinal center B and follicular helper T cells: siblings, cousins or just good friends? [J]. Nat Immunol, 2011,131(6) :472-477.
  • 5Koenders MI, Joosten LA, van den Berg WB. Potential new targets in arthritis therapy interleukin (IL)-17 and its relation to tumour ne- crosk, factor and IL-1 in experimental arthritis [ J ]. Ann Rheum Dis, 2006,65 (Suppl 3 ) :iii29-iii33.
  • 6Lubbcrts E. IL-17/Th17 targeting:on the road to prevent chronic de- structive arthritis? [ J ].Cytokine, 2008,41 (2) : 84-91.
  • 7Lubberts E, Koenders Ml, Oppers- Walgreen B, et al. Treatment with a neutralizing anti-murine interleukin-17 antibody after the on- set of collagen-induced arthritis reduces joint inflammation, carti- lage destruction, and bone erosion [J].Arthritis Rheum, 2004, 50 (2) : 650-659.
  • 8Nakae S, Nambu A, Sudo K, et al. Suppression of immune induction of coltagen-induced arthritis in IL- 17 -deficient mice [ J ]. J Immnnol, 2003,171 ( 11 ) :6173-6177.
  • 9Spolski R, Leonard WJ. interleukin-21 : basic biology and implica- tions for cancer and autoimmunity [J]. Annu Rev Immunol, 2008, 26 : 57-79.
  • 10Konforte D, Simard N, Paige CJ. IL-21 : an executor of B cell fate [J]. Immunol, 2009,182(4) : 1781-1787.

共引文献49

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部